The finally obtained extract was evaporated to dryness and the residue was dissolved in 200 ml of 0.2% (v/v) trifluoroacetic acid solution. An aliquot (50-100 ml) of the resulting solution was loaded onto an HPLC column.
HPLC Analysis The HPLC system consisted of an LC-10AD liquid chromatograph (Shimadzu, Kyoto, Japan) connected to an SCL-10A system controller (Shimadzu) and a DGU-4A degasser (Shimadzu), a 7125 sample injector (Rheodyne, Cotaci, U.S.A.) and a Shim-pack CLC-C8 (M) column (25 cmϫ4.6 mm i.d., particle size of 5 mm, Shimadzu) placed in a CTO-6A column oven (Shimadzu). The separation was performed by delivering the mobile phase, acetonitrile/trifluoroacetic acid/water (18.0 : 0.2 : 81.8, v/v/v), at a flow rate of 1.0 ml/min and at a column temperature of 50°C. Based on spectral measurement and retention time of each analyte, 7, 13) 7-OH-MBC, HMBC, BC, MBC and 7-M-MBC were detected by an RF-550 spectrofluorometric detector (Shimadzu) which was time-programmed as follows: excitation/emission wavelengths (nm) were 325/417 at 0-7.50 min for 7-OH-MBC, 300/447 at 7.50-10.00 min for HMBC and BC, 300/430 at 10.00-14.50 min for MBC and 330/417 at 14.50-18.00 min for 7-M-MBC. An RF-535 fluorometric detector (Shimadzu) was connected in series to detect MTBC, TBC and ETBC at 275 nm for excitation and 350 nm for emission. Beta-carbolines in oxidized-and reduced-form were quantified based on the peak area ratios to HMBC and ETBC, respectively. Their contents in crude drugs were corrected by the recoveries obtained from spiking experiments and the dilution factors.
Analytical Evaluation To evaluate the recovery and analytical precision, a mixture of 7-OH-MBC (0.4-4.0 ng/ml), BC (0.2-2.0 ng/ml), MBC (0.2-2.0 ng/ml), 7-M-MBC (0.4-4.0 ng/ml), MTBC (2.0-20.0 ng/ml) and TBC (2.0-20.0 ng/ml) was added to crude drug diluent samples. Replicate spiked samples were analyzed on the same day (nϭ6 for recovery and intra-assay precision) and on different days (nϭ4 for inter-assay precision) as described above.
Results and Discussion
All analytes including two internal standards were simultaneously analyzed by a single run of HPLC with fluorometric detection specific to each b-carboline as shown by the representative chromatograms (Fig. 1) . The obtained peaks reflect the original contents in crude drugs, not including the artifacts because occurrence of the condensation reaction during analysis was completely suppressed by the fluorescaminepretreatment, in which the samples were reacted with fluorescamine in the first step of an extraction procedure to remove the precursor indoleamines from the analytical system and only the purified original analytes were subjected to HPLC separation. 9, 10) Both recovery and reproducibility were so high that the present method was applicable to the quantitation of b-carbolines in crude drugs as shown by the typical results (Table 1) . More than 80% of the spiked b-carbolines were recovered from the homogenate samples, and intra-and inter-assay CVs were within 8% except for a part of the samples. The quantitative range was 0.01-20.0 ng/ml for MBC and BC, 0.02-20.0 ng/ml for 7-OH-MBC, 0.03-20.0 ng/ml for 7-M-MBC and 0.1-50.0 ng/ml for MTBC and TBC.
Quantitative analyses revealed that b-carboline alkaloids were contained in various crude drugs (Table 2 ). BC and MBC were detected in all those tested. 7-OH-MBC showed relatively wide distribution. However, the presence and content of MTBC, TBC and 7-M-MBC depended on the kind of crude drugs analyzed. Some b-carbolines were previously detected in Rutaceae, Leguminosae, Passifloraceae, Loganiaceae, Plamae, etc.
5) MBC, BC, MTBC and/or TBC were also found in plants belonging to Solanaceae and their products such as tomato, tomato juice, tabasco and tobacco. 4, 10, 13) The present quantitation has proven that the crude drugs cor- Standard: 7-OH-MBC (3.0 ng/ml), BC (1.5 ng/ml), MBC (1.5 ng/ml), 7-M-MBC (3.0 ng/ml), TBC (15.0 ng/ml) and MTBC (15.0 ng/ml). Crude drugs: homogenates of Schisandrae Fructus (10 mg/ml) and Scopoliae Rhizoma (10 mg/ml). Peaks: 1ϭ7-OH-MBC, 2ϭHMBC (internal standard), 3ϭBC, 4ϭMBC, 5ϭ7-M-MBC, 6ϭTBC, 7ϭMTBC and 8ϭETBC (internal standard). responding to that classification uniformly contain b-carboline alkaloids. In particular, Schisandrae Fructus and Pinelliae Tuber contained MTBC at mg/g dry weight levels. Evodiae Fructus was superior in content of BC, MBC and 7-OH-MBC to the other crude drugs. The relatively large amounts of b-carbolines in oxidized-form were present in Scopoliae Rhizoma, Puerariae Radix, Polygalae Radix, Zingiberis Rhizoma, Bupleuri Radix, Passiflora incarnata and Tribulus terrestris. Beta-carbolines have a variety of neuropharmacological activities. 2, 3, 14) They include benzodiazepine antagonism (IC 50 for inhibition of flunitrazepam binding: 5-7 mM for MBC, 6-8 mM for BC, 64 mM for 7-OH-MBC, 920 mM for TBC and 1450 mM for MTBC), 15, 16) inhibition of monoamine oxidase (IC 50 for inhibition of calf liver and mouse brain monoamine oxidase: 0.75 nM-20 mM for BC, 5 nM-3.3 mM for MBC, 15-80 nM for 7-M-MBC, 27.5 nM-5.8 mM for 7-OH-MBC, 42.5 nM-120 mM for MTBC and 58 mM for TBC), 17, 18) and inhibition of biogenic amine uptake (IC 50 for inhibition of serotonin, dopamine and epinephrine uptake: 1.0-6.4 mM for MTBC, 3.0-6.2 mM for TBC and 3.2 mM for 7-M-MBC). 3) Since Schisandrae Fructus and Pinelliae Tuber influence the central nervous system, their major component, MTBC may act as a neuroactive substance. Evodiae Fructus, Passiflora incarnata and Tribulus terrestris have been used as a sedative agent, which may be attributed to BC, MBC, 7-OH-MBC and 7-M-MBC. 6 ) While b-carbolines have the affinity for benzodiazepine receptors, both peripheral-and centraltype benzodiazepine receptors exist in parotid and submandibular glands of rats. 19, 20) Rat xerostomia induced by diazepam was restored by Byakkoka-ninjin-to (45-90 mg/kg, p.o.) and Bakumondo-to (90 mg/kg, p.o.), 21) which contain Pinelliae Tuber, Ginseng Radix and Ophiopogonis Tuber. As an active substance in these crude drugs, b-carbolines may promote salivary secretion by binding to benzodiazepine receptors in salivary glands. Several b-carbolines also show antimicrobial activity against various bacteria and fungi, and their minimal inhibitory concentrations range 0.9-15 mg/disc for BC, 1.9-120 mg/disc for MBC, 100-Ͼ500 mg/ml for 7-OH-MBC and 50-Ͼ500 mg/ml for 7-M-MBC. 22, 23) Therefore, the b-carbolines detected in certain crude drugs traditionally used for intestinal diseases potentially contribute to their therapeutic effects by influencing intestinal microflora. Beta-carboline alkaloids have different activities in addition to their neuroactive and antimicrobial effects, 2, 3, 14) suggesting their potent pharmacological significance in crude drugs.
